The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
Cell & Gene: The Podcast
Intro
This chapter discusses a biopharmaceutical company's breakthroughs in immuno-oncology, particularly their recent FDA submission for a treatment targeting recurrent respiratory papillomatosis. The use of gorilla adenovectors for genetic delivery is also explored, showcasing their potential benefits for future therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
